MULTI DOSE STUDY OF CILOSTAZOL

慢性闭塞性血管疾病产生运动引起的疼痛， 骨骼肌血流量不足并发生局部缺血。 西洛他索具有积极的血管扩张特性， 聚集抑制剂 这项研究将评估安全性和有效性 不同剂量的西洛他唑与安慰剂在患有 这个诊断。 标准化跑步机测试的性能测量 将记录初始和绝对跛行距离的变化。

Chronic occlusive vascular disease produces exercise-induced pain when skeletal muscle blood flow is insufficient and ischemia occurs. Cilostaxol has active vasodilative properties and is a platelet aggregation inhibitor. This study will assess the safety and efficacy of different dosages of cilostazol versus placebo in individuals with this diagnosis. Performance measures on standardized treadmill testing will document changes in initial and absolute claudication distances.